Semaglutide

Yes. Semaglutide is used in several FDA-approved medications. Wegovy® has approved weight-management indications, while Ozempic® is approved for adults with type 2 diabetes.

The right product and dose depend on your health, goals, and medical needs.

Semaglutide works on the GLP-1 receptor. Tirzepatide works on both GIP and GLP-1 receptors.

One is not automatically better for every patient. Your provider will consider your health history, goals, previous response, tolerability, and insurance coverage.

Standard Wegovy® injection dosing begins at 0.25 mg once weekly for 4 weeks and generally progresses through 0.5 mg, 1 mg, 1.7 mg, and the usual 2.4 mg maintenance dose.

A 7.2 mg Wegovy® injection dose is also available as a higher-dose option for certain adults. It is not an automatic next step for every patient.

Not necessarily. The dose ladder is a guide, not a goal.

If your current dose is working well and you are tolerating it comfortably, your provider may recommend staying at that dose rather than automatically increasing it.

The 7.2 mg once-weekly Wegovy® injection is an FDA-approved higher-dose option for certain adults.

It is separate from compounded semaglutide dosing, and your provider will determine whether that dose is appropriate for you.

Yes. FDA-approved oral semaglutide products are available, including an oral Wegovy® formulation for approved adult indications.

Oral and injectable versions use different dosing instructions and are not interchangeable milligram-for-milligram.

Some patients notice changes in appetite or fullness during the first several weeks. Changes in weight and body composition usually develop more gradually.

Everyone responds differently, which is why follow-up and individualized dosing matter.

Results vary based on starting weight, dose, treatment duration, nutrition, physical activity, metabolic health, adherence, and individual response.

At Alpha Hormones®, we also look beyond the number on the scale by monitoring lean muscle, body fat, visceral fat, and other metabolic markers when appropriate.

Any significant weight loss can include some loss of lean mass as well as body fat, so preserving muscle is an important part of a well-managed program.

Adequate protein, resistance training, appropriate nutrition, and body-composition monitoring can help support lean muscle during treatment.

Common side effects may include nausea, reduced appetite, diarrhea, constipation, vomiting, abdominal discomfort, indigestion, reflux, or early fullness. These may be more noticeable when starting treatment or increasing the dose.

Less common but more serious risks can also occur. Your provider will review the risks most relevant to your medical history before treatment.

In some patients, hormone therapy and semaglutide can be part of the same overall treatment plan when each treatment is medically appropriate.

Your provider will review your hormone treatment, laboratory results, medications, metabolic health, and weight-management goals before making a recommendation.

Yes. Alpha Hormones® takes a comprehensive approach to medical weight management rather than focusing only on GLP-1 medication.

Depending on your symptoms and history, your evaluation may include thyroid function, hormones, insulin resistance, blood sugar, lipids, medications, sleep, nutrition, physical activity, stress, and body composition.

Semaglutide is only one of several medical weight-management options. Your provider may discuss tirzepatide, phentermine, Qsymia®, Contrave®, other prescription options, nutrition and lifestyle strategies, or treatment of underlying metabolic or hormonal factors.

The goal is to choose the strategy that makes the most sense for your health and goals.

Compounded semaglutide may be discussed when legally permitted and clinically appropriate for an individual patient.

Eligible compounded treatment starts at $249 per month, with medical management included and no required monthly membership.

Pricing may vary based on prescribed dose, pharmacy, shipping, and supplies. Compounded semaglutide is not FDA-approved and is different from Wegovy® and Ozempic®.

Yes. Our team can review your insurance benefits and see whether an appropriate FDA-approved semaglutide medication may be covered by your plan.

If prior authorization is required, we can help submit the relevant clinical information and supporting documentation.

Coverage varies by plan and approval is not guaranteed, but we can help you understand the process and available options.

Semaglutide is generally not used together with another semaglutide-containing medication or another GLP-1 medication. Tirzepatide also has GLP-1 receptor activity.

Your provider can help you safely transition between treatments when appropriate.

Appetite and weight can increase again after stopping treatment, especially if the factors contributing to weight gain are still present.

Your provider can help build a longer-term maintenance strategy using nutrition, resistance training, activity, metabolic or hormonal treatment when appropriate, and ongoing follow-up.

Eligible medical consultations, laboratory testing, and prescribed medications may qualify for HSA or FSA payment. Check with your plan administrator for the rules that apply to your specific account.

Unverified products may contain the wrong concentration, unexpected ingredients, contaminants, or may not contain what the seller claims.

Alpha Hormones® prescribes through appropriately licensed U.S. pharmacies and recommends obtaining prescription medication through legitimate medical and pharmacy channels.

Our approach goes beyond simply prescribing a GLP-1 medication. We evaluate metabolic health, hormones when appropriate, current medications, nutrition, physical activity, body composition, and other factors that may influence your weight.

We also offer multiple medication options, individualized dosing, insurance and prior authorization support, flexible self-pay options, and ongoing medical monitoring as your treatment plan evolves.